Medication adherence and management of risk factors for secondary stroke preventio
Not Applicable
Completed
- Conditions
- Secondary prevention of stroke among stroke survivorsCirculatory SystemStroke, not specified as haemorrhage or infarction
- Registration Number
- ISRCTN31718066
- Lead Sponsor
- World Stroke Organization
- Brief Summary
2022 Protocol article in https://www.annalsofian.org/text.asp?2022/25/6/1153/362587 (added 02/02/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 208
Inclusion Criteria
1. Adult (aged >18 years) patients with onset of stroke within 1 month
2. Severity: Modified Rankin Scale (mRS) <5
3. Presence of one or more vascular risk factors such as hypertension, diabetes mellitus, smoking and dyslipidaemia
4. Patients who could fully understand the use of an Android-based smartphone
Exclusion Criteria
1. Patients with severe disability: mRS >4
2. Patients who do not consent
3. Severe cognitive impairment
4. Stroke survivor without a primary caregiver in patients with mRS 3 and 4
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Medication adherence assessed using the Morisky Medication-Taking Adherence Scale (MMAS 4) at baseline, 3 and 6 months<br>2. Lifestyle and behavioral factors assessed using WHO STEPS instrument, physical activity questionnaire, and FADS questionnaire at baseline, 3 and 6 months<br>3. Control of vascular risk factors (fasting blood sugar, HbA1c, lipid profile and blood values) measured using standard techniques in the laboratory at baseline, 3 and 6 months
- Secondary Outcome Measures
Name Time Method 1. Vascular events (TIA/stroke/cardiac events/vascular deaths) measured using adverse events data updated within patient medical records at 6 months<br>2. Functional outcomes measured using the Modified Rankin Scale (mRS) at baseline, 3 and 6 months